Oric Pharmaceuticals
ORIC
ORIC
122 hedge funds and large institutions have $715M invested in Oric Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.25% less ownership
Funds ownership: 100.23% → 98.98% (-1.2%)
Holders
122
Holding in Top 10
4
Calls
$155K
Puts
$8K
Top Buyers
| 1 | +$14.8M | |
| 2 | +$11.6M | |
| 3 | +$9.73M | |
| 4 |
BlackRock
New York
|
+$2.78M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$2.54M |
Top Sellers
| 1 | -$5.55M | |
| 2 | -$5.01M | |
| 3 | -$3.26M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.11M |
| 5 |
O
OrbiMed
New York
|
-$2.03M |